• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症患者的RNA代谢:尿毒症血清中修饰核糖核苷的积累。技术说明。

RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note.

作者信息

Niwa T, Takeda N, Yoshizumi H

机构信息

Nagoya University Daiko Medical Center, Japan.

出版信息

Kidney Int. 1998 Jun;53(6):1801-6. doi: 10.1046/j.1523-1755.1998.00944.x.

DOI:10.1046/j.1523-1755.1998.00944.x
PMID:9607216
Abstract

To determine the metabolism of ribonucleic acid (RNA) in uremia, serum and urine levels of ribonucleosides in uremic patients were analyzed using reversed-phase high-performance liquid chromatography. The serum levels of xanthosine and all modified ribonucleosides were increased in undialyzed patients with chronic renal failure (CRF), and patients undergoing hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). The serum level of pseudouridine was markedly increased in all the uremic patients especially CAPD patients (32 times higher than normal). By contrast, the serum level of adenosine did not show any significant change in the uremic patients. Interestingly, the serum and urine levels of inosine were significantly decreased in all the uremic patients, suggesting that the production of inosine is decreased in uremic patients. The serum level of uridine was significantly elevated only in the HD patients. The serum levels of all ribonucleosides except inosine and uridine decreased significantly after HD. The urinary excretion of inosine, 1-methyladenosine, 1-methylguanosine, N2,N2-dimethylguanosine and N4-acetylcytidine was significantly decreased in the CRF patients, leading to the accumulation of these modified ribonucleosides in the uremic serum. CAPD patients showed markedly increased serum levels of modified ribonucleosides such as pseudouridine, 1-methylinosine, and N2,N2-dimethylguanosine and N4-acetylcytidine as compared with the HD patients. These results demonstrate that there was an altered metabolism of RNA in uremic patients with marked accumulation of modified ribonucleosides.

摘要

为了确定尿毒症患者体内核糖核酸(RNA)的代谢情况,采用反相高效液相色谱法分析了尿毒症患者血清和尿液中核糖核苷的水平。慢性肾衰竭(CRF)未透析患者、接受血液透析(HD)和持续性非卧床腹膜透析(CAPD)的患者,其血清中黄嘌呤核苷及所有修饰核糖核苷的水平均升高。所有尿毒症患者,尤其是CAPD患者,其假尿苷的血清水平显著升高(比正常水平高32倍)。相比之下,尿毒症患者血清中腺苷水平无显著变化。有趣的是,所有尿毒症患者血清和尿液中次黄苷水平均显著降低,提示尿毒症患者次黄苷生成减少。仅HD患者的尿苷血清水平显著升高。HD后,除次黄苷和尿苷外,所有核糖核苷的血清水平均显著降低。CRF患者尿液中次黄苷、1-甲基腺苷、1-甲基鸟苷、N2,N2-二甲基鸟苷和N4-乙酰胞苷的排泄显著减少,导致这些修饰核糖核苷在尿毒症血清中蓄积。与HD患者相比,CAPD患者血清中修饰核糖核苷如假尿苷、1-甲基次黄苷、N2,N2-二甲基鸟苷和N4-乙酰胞苷的水平显著升高。这些结果表明,尿毒症患者存在RNA代谢改变,且修饰核糖核苷明显蓄积。

相似文献

1
RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note.尿毒症患者的RNA代谢:尿毒症血清中修饰核糖核苷的积累。技术说明。
Kidney Int. 1998 Jun;53(6):1801-6. doi: 10.1046/j.1523-1755.1998.00944.x.
2
Liquid-chromatographic profiling of solutes in serum of uremic patients undergoing hemodialysis and chronic ambulatory peritoneal dialysis (CAPD); high concentrations of pseudouridine in CAPD patients.接受血液透析和持续性非卧床腹膜透析(CAPD)的尿毒症患者血清中溶质的液相色谱分析;CAPD患者中假尿苷的高浓度。
Clin Chem. 1988 Jan;34(1):91-7.
3
Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
Am J Nephrol. 1993;13(4):238-43. doi: 10.1159/000168626.
4
The influence of uremic serum on interleukin-1beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells.尿毒症血清对外周血单核细胞产生白细胞介素-1β及白细胞介素-1受体拮抗剂的影响。
Ther Apher Dial. 2006 Feb;10(1):65-71. doi: 10.1111/j.1744-9987.2006.00346.x.
5
Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.
Nephron. 1996;74(1):72-8. doi: 10.1159/000189284.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.尿毒症患者的网织血小板:血液透析和持续性非卧床腹膜透析的影响
Am J Hematol. 1995 Nov;50(3):161-6. doi: 10.1002/ajh.2830500303.
8
Oxalic Acid as a uremic toxin.草酸作为一种尿毒症毒素。
J Ren Nutr. 2008 Jan;18(1):33-9. doi: 10.1053/j.jrn.2007.10.008.
9
The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.非糖尿病终末期肾病患者血液透析和持续性非卧床腹膜透析时胰岛素敏感性的测定
Saudi Med J. 2005 May;26(5):786-91.
10
High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.接受持续非卧床腹膜透析治疗的尿毒症患者血清脂蛋白(a)浓度高。
Clin Nephrol. 1992 Nov;38(5):271-6.

引用本文的文献

1
Binding Capacity and Adsorption Stability of Uremic Metabolites to Albumin-Modified Magnetic Nanoparticles.尿毒症代谢产物与白蛋白修饰磁性纳米颗粒的结合能力及吸附稳定性
Int J Mol Sci. 2025 Jun 3;26(11):5366. doi: 10.3390/ijms26115366.
2
Risk Factors for Chronic Kidney Disease in Patients With Crohn's Disease.克罗恩病患者慢性肾脏病的危险因素
Inflamm Bowel Dis. 2025 Oct 1;31(10):2693-2703. doi: 10.1093/ibd/izaf039.
3
A Fluorescent Aptasensor for Sensitive and Selective Determination of Epigenetic Cancer Biomarker N-Methyladenosine in Urine Samples.
一种用于灵敏且选择性测定尿液样本中表观遗传癌症生物标志物N-甲基腺苷的荧光适配体传感器。
Chemistry. 2025 May 14;31(27):e202500105. doi: 10.1002/chem.202500105. Epub 2025 Apr 16.
4
NAT10-mediated mRNA -acetylation is essential for the translational regulation during oocyte meiotic maturation in mice.NAT10介导的mRNA乙酰化对于小鼠卵母细胞减数分裂成熟过程中的翻译调控至关重要。
Sci Adv. 2025 Feb 21;11(8):eadp5163. doi: 10.1126/sciadv.adp5163.
5
RNA N4-acetylcytidine modification and its role in health and diseases.RNA N4-乙酰胞苷修饰及其在健康与疾病中的作用。
MedComm (2020). 2025 Jan 3;6(1):e70015. doi: 10.1002/mco2.70015. eCollection 2025 Jan.
6
Serum and Urine Metabolites and Kidney Function.血清和尿液代谢物与肾功能
J Am Soc Nephrol. 2024 Jun 6;35(9):1252-65. doi: 10.1681/ASN.0000000000000403.
7
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade.一碳单位补充剂为肿瘤浸润 T 细胞中的嘌呤合成提供燃料,并增强检查点阻断。
Cell Chem Biol. 2024 May 16;31(5):932-943.e8. doi: 10.1016/j.chembiol.2024.04.007.
8
Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.与慢性肾脏病患者尿毒症症状相关的代谢物:来自慢性肾功能不全队列(CRIC)研究的结果。
Am J Kidney Dis. 2024 Jul;84(1):49-61.e1. doi: 10.1053/j.ajkd.2023.11.013. Epub 2024 Jan 23.
9
One-carbon unit supplementation fuels tumor-infiltrating T cells and augments checkpoint blockade.补充一碳单位为肿瘤浸润性T细胞提供能量并增强免疫检查点阻断作用。
bioRxiv. 2023 Nov 3:2023.11.01.565193. doi: 10.1101/2023.11.01.565193.
10
NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway.NAT10使BCL-XL信使核糖核酸乙酰化,通过PI3K-AKT途径促进多发性骨髓瘤细胞的增殖。
Front Oncol. 2022 Aug 1;12:967811. doi: 10.3389/fonc.2022.967811. eCollection 2022.